JOURNAL OF CHEMICAL RESEARCH 2009 675
Table 1 Synthesis of compounds 5a–f
Entry
R1
R2
Mode of
activation
Time
Power/
temp.
Yield/%
5a
5b
5c
5d
5e
5f
4-Methoxy
3,5-Dimethyl
2,4-Dichloro
3,5-Dimethyl
3-Fluoro
2,6-Difluoro
2,6-Difluoro
4-Methoxy
4-Methoxy
H
MW
MW
MW
MW
MW
MW
6 min
7 min
6 min
6 min
6 min
6 min
300 W
300 W
300 W
300 W
300 W
300 W
87
83
82
78
90
85
4-Methoxy
H
5a
4-Methoxy
2,6-Difluoro
CH
5 h
110oC
52
MW = microware irradiation; CH = conventional heating.
to raise temperature until reflux and stirred for 4 h. After cooling,
50 mL water was added into the reaction mixture. The pH of the
reaction solution was adjusted to the range of 8–9 with 50% NaOH
solution. The crude product precipitated, filtered, washed with water,
dried, and recrystallised from ethanol to afford compounds 3a–d.
N-[5-(3-fluorophenyl)-1,3,4-thiadiazol-2-ylcarbamoyl]benzamide 5e:
(90%): M.p. 249–250°C, H NMR(DMSO-d6, 300 MHz) d: 7.37–
1
8.06 (m, 9H, ArH), 11.66 (s, 1H, NH),12.22 (s, 1H, NH), IR(KBr)
υ: 680 (C-S), 1594 (C=N), 3296 (N-H), 1691 (C=O) cm-1; Anal.
Calcd for C16H11FN4O2S: C, 56.13; H, 3.24; N, 16.37. Found: C,
56.17; H, 3.28; N, 16.30%.
N-[5-(4-methoxyphenyl)-1,3,4-thiadiazol-2-ylcarbamoyl]benzamide
5f: (85%): M.p. 296–297°C, 1H NMR(DMSO-d6, 300 MHz) d: 3.84
(s, 3H, OCH3), 6.99–8.04 (m, 9 H, ArH), 11.61 (s, 1H, NH),12.12
(s, 1H, NH), IR(KBr)υ: 669 (C-S), 1604 (C=N), 3236 (N-H), 1703
(C=O) cm-1; Anal. Calcd for C17H14N4O3S: C, 57.62; H, 3.98; N,
15.81. Found: C, 57.57; H, 3.90; N, 15.93%.
The compound 5a was subjected to single crystal X-ray
crystallography and intensity data were collected 298(2) K on the
Enraf-Nonius CAD-4 diffractometer and use graphite Monochromatic
MoKa radiation (l = 0.71073Å). The structure was solved and refined
with the SHELXL-97 program.15 All H atoms bonded to the C atoms
were placed geometrically and constrained to ride on their parent
atoms. The thermal ellipsoids were plotted with the SHELXL-97
program at 50% probability. The molecular structure is shown in Fig. 1.
Selected crystal data and structure refinement details are listed in
Table 2. Selected bond distances and angles are listed in Table 3.
General synthetic procedure for the preparation of 4a–c
A mixture of substituted benzamide 2a–c (0.1 mol) and ethylene
dichloride was chilled in an ice bath and stirred while oxalyl
dichloride (0.24 mol) was added dropwise to the mixture.
The mixture was warmed and stirred for 1 h at room temperature,
and then heated to reflux for 5 h. After completion of the reaction, the
remaining oxalyl chloride was evaporated under reduced pressure.
The compounds 4a–c was collected under vacuum.
General synthetic procedure for the preparation of 5a–f
A mixture of compounds 3a–d (0.01 mol) and 4a–c (0.014 mol) in
toluene was stirred and irradiated in WF-4000M microwave fast
reaction system under 300W for minutes. After cooling and filtering,
crude compound 5a–f was obtained. Pure compound was obtained
by recrystallisation from DMF.
Crystals of (5a) suitable for X-ray diffraction were obtained by slow
evaporation of a DMF solution.
N-[5-(4-methoxyphenyl)-1,3,4-thiadiazol-2-ylcarbamoyl]-2,6-
difluorobenzamide 5a: (87%): M.p. 203–205°C, 1H NMR(DMSO-d6,
300 MHz) d: 3.84(s, 3H, OCH3), 7.07–7.90(m, 7H, ArH), 11.73(s,
2H, NH), IR(KBr)υ: 679(C-S), 1632(C=N), 3203(N-H), 1696(C=O)
cm-1; Anal. Calcd for C17H12F2N4O3S: C, 52.31; H, 3.10; N, 14.35.
Found: C, 52.26; H, 3.11; N, 14.30%.
N-[5-(3,5-dimethylphenyl)-1,3,4-thiadiazol-2-ylcarbamoyl]-2,6-
difluorobenzamide 5b: (83%): M.p. 256–257°C, 1H NMR(DMSO-d6,
300 MHz) d: 2.34 (s, 6H, CH3), 7.16–7.66 (m, 6H, ArH),11.72 (s,
2H, NH), IR(KBr)υ: 670 (C-S), 1625 (C=N), 3123 (N-H), 1695
(C=O) cm-1; Anal. Calcd for C18H14F2N4O2S: C, 55.66; H, 3.63; N,
14.43. Found: C, 55.62; H, 3.71; N, 14.41%.
N-[5-(2,4-dichlorophenyl)-1,3,4-thiadiazol-2-ylcarbamoyl]-4-
methoxybenzamide 5c: (82%): M.p. 272–274°C,1H NMR(DMSO-d6,
300 MHz) d: 3.86 (s, 3H, OCH3),7.09–8.28 (m, 7 H, ArH),11.52 (s,
1H, NH),12.37 (s, 1H, NH), IR(KBr)υ: 686 (C-S), 1604 (C=N), 3151
(N-H), 1699 (C=O) cm-1; Anal. Calcd for C17H12Cl2N4O3S: C, 48.24;
H, 2.86; N, 13.24. Found: C, 48.30; H, 2.82; N 13.20%.
N-[5-(3,5-dimethylphenyl)-1,3,4-thiadiazol-2-ylcarbamoyl]-4-
methoxybenzamide 5d: (78%): M.p. 264–265°C, 1H NMR(DMSO-d6,
300 MHz) d: 2.54 (s, 6H, CH3), 3.87 (s, 3H, OCH3), 7.09–8.09 (m, 7 H,
ArH), 11.51 (s, 1 H, NH),12.29 (s, 1H, NH), IR(KBr)υ: 688 (C-S), 1604
(C=N), 3286 (N-H), 1699 (C=O) cm-1; Anal. Calcd for C19H18N4O3S:
C, 59.67; H, 4.74; N 14.65. Found: C, 59.67; H, 4.72; N, 14.69%.
Table 2 Crystal data and structure refinement for C17H12F2N4O3S
Empirical formula
Formula weight
Temperature
C17H12F2N4O3S
383.48 g mol-1
298(2) K
Wavelength
0.71073 Å
Crystal system
Space group
Monoclinic
C 2/c
23.853(5) Å
Unit cell dimensions
7.1360(14)Å b = 109.55(3)
22.370(5) Å
Volume
Z
Absorption correction
F(000)
Absorption coefficient
θrange for entire data collection
Reflections collected
Independent reflections
Data/restraints/parameters
Final R indices [I>2σ>(I)]
3588.2(12) Å-3
8
Psi-scan
1660
0.232 mm-1
1.81°to 25.34°
3354
3271 (Rint = 0.0360)
2331/0/254
R1 = 0.0817, wR2 = 0.1677
R1 = 0.0556, wR2 = 0.1468
1.005
Goodness-of-fit on F2
Final residual electron density
0.368 and –0.352 e. Å-3
Fig.1 A view of the molecular structure of 5a, showing atom displacement ellipsoids at the 50% level.